HRP20090350T1 - Injectable liquid paracetamol formulation - Google Patents

Injectable liquid paracetamol formulation

Info

Publication number
HRP20090350T1
HRP20090350T1 HR20090350T HRP20090350T HRP20090350T1 HR P20090350 T1 HRP20090350 T1 HR P20090350T1 HR 20090350 T HR20090350 T HR 20090350T HR P20090350 T HRP20090350 T HR P20090350T HR P20090350 T1 HRP20090350 T1 HR P20090350T1
Authority
HR
Croatia
Prior art keywords
paracetamol
solution
injectable liquid
paracetamol formulation
liquid paracetamol
Prior art date
Application number
HR20090350T
Other languages
English (en)
Croatian (hr)
Inventor
Huertas M�noz Faustino
Fern�ndez L�garo Ra�l
Original Assignee
Genfarma Laboratorio S.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38474429&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20090350(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genfarma Laboratorio S.L. filed Critical Genfarma Laboratorio S.L.
Publication of HRP20090350T1 publication Critical patent/HRP20090350T1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
HR20090350T 2006-07-18 2009-06-16 Injectable liquid paracetamol formulation HRP20090350T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ES2006/070108 WO2008009756A1 (es) 2006-07-18 2006-07-18 Formulación líquida inyectable de paracetamol

Publications (1)

Publication Number Publication Date
HRP20090350T1 true HRP20090350T1 (en) 2009-08-31

Family

ID=38474429

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20090350T HRP20090350T1 (en) 2006-07-18 2009-06-16 Injectable liquid paracetamol formulation

Country Status (17)

Country Link
US (2) US9943479B2 (ru)
EP (2) EP2100596A3 (ru)
JP (1) JP4929352B2 (ru)
AT (1) ATE432690T1 (ru)
AU (2) AU2006346318B2 (ru)
CA (1) CA2628806C (ru)
CY (1) CY1110480T1 (ru)
DE (1) DE602007001215D1 (ru)
DK (1) DK1889607T3 (ru)
ES (1) ES2327286T3 (ru)
HR (1) HRP20090350T1 (ru)
MA (1) MA31346B1 (ru)
PL (1) PL1889607T3 (ru)
PT (1) PT1889607E (ru)
RU (1) RU2419421C2 (ru)
SI (1) SI1889607T1 (ru)
WO (1) WO2008009756A1 (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2926992B1 (fr) * 2008-02-06 2011-01-14 Moly Pharma Formulation d'une solution de paracetamol injectable,procede de preparation et de conditionnement d'une telle solution et dispositif de conditionnement d'une telle solution
EP2243477A1 (de) 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol zur parenteralen Verabreichung
US8404748B2 (en) 2009-08-13 2013-03-26 Neogen N.V. Storage-stable formulation of paracetamol in aqueous solution
IN2012DN05192A (ru) 2010-01-21 2015-10-23 Aprea Ab
ES2389760T3 (es) 2010-04-14 2012-10-31 B. Braun Melsungen Ag Composición de acetaminofeno
ES2414557B1 (es) 2012-01-16 2014-06-10 Novocat Farma, S.A. Composición acuosa de paracetamol para inyección
ITMI20121154A1 (it) * 2012-06-29 2013-12-30 Sint Sa Soluzione iniettabile di acetaminofene per la somministrazione spinale
ZA201300398B (en) * 2012-11-27 2013-09-25 Genfarma Laboratories S L Injectable liquid formulation of the combination of tramadol and paracetamol
US20140303254A1 (en) * 2013-04-08 2014-10-09 InnoPharma Licensing LLC Process Of Manufacturing A Stable, Ready To Use Infusion Bag For An Oxidation Sensitive Formulation
BR102014005885B1 (pt) * 2014-03-13 2021-04-13 Biotec Biológica Indústria Farmacêutica Ltda E.P.P Formulação farmacêutica líquida injetável estável de paracetamol em bolsa plástica pronta para uso
WO2016013049A1 (en) * 2014-07-25 2016-01-28 Terumo Kabushiki Kaisha Packaged acetaminophen injection solution preparation
PT3411004T (pt) * 2016-02-05 2021-05-11 Innopharma Inc Processo de fabrico de um saco de perfusão estável e pronto para utilização para uma formulação sensível à oxidação

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440815A (en) 1981-06-29 1984-04-03 Abbott Laboratories Clear, autoclavable plastic formulation for medical liquid containers
FR2751875B1 (fr) 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
KR100226191B1 (ko) 1997-04-03 1999-10-15 구광시 음료용 플라스틱 병
EP1027835B1 (en) * 1997-10-23 2008-09-17 Morinaga Milk Industry Co., Ltd. Method and apparatus for continuous heat sterilization of liquid
PT916347E (pt) * 1997-11-18 2003-07-31 Uni Pharma Kleon Tsetis A B E Solucoes farmaceuticas injectaveis contendo paracetamol e combinacoes de paracetamol com outras substancias activas
IT1301976B1 (it) 1998-07-31 2000-07-20 Angelini Ricerche Spa Composizione farmaceutica iniettabile a base di paracetamolo
FR2809619B1 (fr) * 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
DE10112325A1 (de) 2001-03-13 2002-10-02 Fresenius Kabi De Gmbh Lagerstabile Fertiginfusionslösungen des Paracetamols
ITMI20012135A1 (it) 2001-10-16 2003-04-16 Bioren S A Soluzioni iniettabili pronte all'uso di paracetamolo
HUP0402549A3 (en) 2001-12-18 2006-01-30 Tseti Ioulia Parenteral composition of paracetamol
JP4446387B2 (ja) * 2002-05-27 2010-04-07 杏林製薬株式会社 (2s)−2−エチルフェニルプロピオン酸誘導体
AU2003251152A1 (en) 2002-07-03 2004-01-23 Shannon Biotechnology Ltd Pharmaceutical formulations for preparing drink products
FR2851164B1 (fr) 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
FR2862872A1 (fr) 2003-12-02 2005-06-03 Palbian Snc Composition a l'etat aqueux pour l'application perfusable d'un principe actif, notamment pharmacologique tel que le paracetamol.
US20060292225A1 (en) 2005-06-24 2006-12-28 Felix Arthur M Water soluble analgesic formulations and methods for production

Also Published As

Publication number Publication date
DK1889607T3 (da) 2009-07-27
AU2011201253B2 (en) 2012-03-29
EP1889607B1 (en) 2009-06-03
RU2419421C2 (ru) 2011-05-27
EP1889607A1 (en) 2008-02-20
EP2100596A3 (en) 2010-04-28
MA31346B1 (fr) 2010-05-03
EP2100596A2 (en) 2009-09-16
ES2327286T3 (es) 2009-10-27
US20160199325A1 (en) 2016-07-14
JP2009543851A (ja) 2009-12-10
JP4929352B2 (ja) 2012-05-09
AU2006346318B2 (en) 2011-02-10
AU2006346318A1 (en) 2008-01-24
CA2628806C (en) 2012-08-21
RU2009105480A (ru) 2010-08-27
US9943492B2 (en) 2018-04-17
DE602007001215D1 (de) 2009-07-16
CY1110480T1 (el) 2015-04-29
US9943479B2 (en) 2018-04-17
AU2011201253A1 (en) 2011-04-07
WO2008009756A1 (es) 2008-01-24
ATE432690T1 (de) 2009-06-15
SI1889607T1 (sl) 2009-10-31
CA2628806A1 (en) 2008-01-24
PT1889607E (pt) 2009-07-20
US20090215903A1 (en) 2009-08-27
PL1889607T3 (pl) 2009-10-30

Similar Documents

Publication Publication Date Title
PL1889607T3 (pl) Iniekcyjny ciekły produkt leczniczy zawierający paracetamol
EA201070001A1 (ru) Водная композиция, содержащая соль, способ её получения и применения
MX2007012947A (es) Composiciones biomejoradas.
TW200605872A (en) Alcohol-metabolism enhancing composition and ingesta containing the same
TW200633951A (en) Method for reducing cyclohexenone content of a cyclohexenone-containing organic mixture
BRPI0706966A8 (pt) Composição para um efeito microbicida em um sistema de água, método para estabilizar cloro para ser utilizado como um biocida no tratamento de água em um sistema de processamento, e método para tratar um sistema de água de processamento de papel
WO2005115416A3 (en) Method of treating with chlorine dioxide
EP2096440A4 (en) METHOD FOR STABILIZING -THROMBIN IN THROMBIN CONTAINING SOLUTION
ATE367167T1 (de) Aufbereitung von aldesleukin zur pharmazeutischen verwendung
ATE518888T1 (de) Stabilisierte lösung mit hoher igm-konzentration
IL161390A0 (en) Ready-to-use- paracetamol injection solutions containing propylene glycol as the only cosolvent
PH12019502849A1 (en) Hypochlorous acid sterilizing water composition
SG159481A1 (en) Stabilization of thermolysin in aqueous solution
BRPI0513244A (pt) composto de clatrato, método para controlar a concentração de solução aquosa de ingrediente ativo quìmico agrìcola e formulação quìmica agrìcola
CN103499574A (zh) 铝离子检测试纸及其制备方法和使用方法
DE50209881D1 (de) Herstellung von dialysekonzentrat aus einer hochverdichteten konzentratvorstufe und vorrichtung zur anwendung am dialyseplatz.
UA92218C2 (ru) Способ получения стабильного при хранении биодизельного топлива
CN103743733B (zh) 一氧化碳检测试剂
BR112012018427A2 (pt) uso de composto, e, método para aumentar o ph de uma suspensão aquosa
Li Simultaneous determination of phthalate esters by micelle capillary electrophoresis
TH84738B (th) การใช้ 1-ฟีน็อกซี-2-โพรพานอล(1-phenoxy-2-propanol)เป็นตัวช่วยสูตรสีย้อม
Su Mechanism of Hg (II) biosorption by saccharomyces cerevisiae
RS51179B (sr) Tečne injektabilne formulacije paracetamola
Tu et al. The construct of a neutral medium applicable electrochemiluminescent sensor based on the chemical modification of cysteine and luminol.
UA83157C2 (ru) Сорбент для извлечения ионов fe 2+ из водных растворов и физиологических жидкостей